GB2304340B - (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy} butyric acid as cellular adhesion inhibitor - Google Patents

(-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy} butyric acid as cellular adhesion inhibitor

Info

Publication number
GB2304340B
GB2304340B GB9627127A GB9627127A GB2304340B GB 2304340 B GB2304340 B GB 2304340B GB 9627127 A GB9627127 A GB 9627127A GB 9627127 A GB9627127 A GB 9627127A GB 2304340 B GB2304340 B GB 2304340B
Authority
GB
United Kingdom
Prior art keywords
piperazin
phenoxy
pyridyl
methyl
butyric acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB9627127A
Other versions
GB2304340A (en
GB9627127D0 (en
Inventor
Stuart Dennett Mills
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syngenta Ltd
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/457,538 external-priority patent/US5652242A/en
Priority claimed from GBGB9518188.9A external-priority patent/GB9518188D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of GB9627127D0 publication Critical patent/GB9627127D0/en
Publication of GB2304340A publication Critical patent/GB2304340A/en
Application granted granted Critical
Publication of GB2304340B publication Critical patent/GB2304340B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GB9627127A 1995-06-01 1996-05-28 (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy} butyric acid as cellular adhesion inhibitor Expired - Fee Related GB2304340B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/457,538 US5652242A (en) 1993-03-29 1995-06-01 Heterocyclic derivatives
GBGB9518188.9A GB9518188D0 (en) 1995-09-07 1995-09-07 Optically active derivative
PCT/GB1996/001260 WO1996038416A1 (en) 1995-06-01 1996-05-28 (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy} butyric acid as cellular adhesion inhibitor

Publications (3)

Publication Number Publication Date
GB9627127D0 GB9627127D0 (en) 1997-02-19
GB2304340A GB2304340A (en) 1997-03-19
GB2304340B true GB2304340B (en) 1998-07-29

Family

ID=26307696

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9627127A Expired - Fee Related GB2304340B (en) 1995-06-01 1996-05-28 (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy} butyric acid as cellular adhesion inhibitor

Country Status (31)

Country Link
EP (1) EP0796247A1 (en)
JP (1) JP2885941B2 (en)
KR (1) KR100245957B1 (en)
AT (1) AT406675B (en)
AU (1) AU710105B2 (en)
BE (1) BE1009520A5 (en)
BR (1) BR9606409A (en)
CA (1) CA2194397A1 (en)
CH (1) CH691808A5 (en)
CZ (1) CZ26997A3 (en)
DE (1) DE19680509T1 (en)
DK (1) DK10697A (en)
ES (1) ES2137886B1 (en)
FI (1) FI970393A (en)
GB (1) GB2304340B (en)
GR (1) GR1002702B (en)
HU (1) HUP9700274A3 (en)
IE (1) IE960405A1 (en)
IL (1) IL118477A0 (en)
IT (1) IT1290839B1 (en)
LU (1) LU90008B1 (en)
MC (1) MC2418A1 (en)
MX (1) MX9700379A (en)
NL (1) NL1003243C2 (en)
NO (1) NO307460B1 (en)
NZ (1) NZ308597A (en)
PL (1) PL318440A1 (en)
SE (1) SE510812C2 (en)
SK (1) SK13097A3 (en)
TR (1) TR199700020T1 (en)
WO (1) WO1996038416A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994022834A1 (en) * 1993-03-29 1994-10-13 Zeneca Limited Heterocyclic derivatives as platelet aggregation inhibitors
WO1994022835A2 (en) * 1993-03-29 1994-10-13 Zeneca Limited Heterocyclic compounds as platelet aggregation inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0100158A3 (en) * 1982-07-28 1985-03-27 The Upjohn Company (3-pyridinyl)heteroalkarylalkanols, alkanoic acids and esters
GB8609630D0 (en) * 1986-04-19 1986-05-21 Pfizer Ltd Anti-arrhythmia agents

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994022834A1 (en) * 1993-03-29 1994-10-13 Zeneca Limited Heterocyclic derivatives as platelet aggregation inhibitors
WO1994022835A2 (en) * 1993-03-29 1994-10-13 Zeneca Limited Heterocyclic compounds as platelet aggregation inhibitors

Also Published As

Publication number Publication date
MC2418A1 (en) 1997-05-23
NO970437D0 (en) 1997-01-31
FI970393A0 (en) 1997-01-30
BR9606409A (en) 1997-09-30
TR199700020T1 (en) 1997-04-22
HUP9700274A3 (en) 2000-02-28
NO307460B1 (en) 2000-04-10
HU9700274D0 (en) 1997-04-28
GR1002702B (en) 1997-05-22
FI970393A (en) 1997-01-30
ITMI961113A0 (en) 1996-05-31
DE19680509T1 (en) 1997-12-04
NO970437L (en) 1997-02-20
LU90008B1 (en) 1997-04-16
JP2885941B2 (en) 1999-04-26
ES2137886B1 (en) 2000-08-16
AU5827296A (en) 1996-12-18
MX9700379A (en) 1997-04-30
AU710105B2 (en) 1999-09-16
ATA900596A (en) 1999-12-15
CH691808A5 (en) 2001-10-31
SE9700203D0 (en) 1997-01-24
NZ308597A (en) 1998-11-25
SE9700203L (en) 1997-01-24
SK13097A3 (en) 1997-08-06
ITMI961113A1 (en) 1997-12-01
PL318440A1 (en) 1997-06-09
GB2304340A (en) 1997-03-19
KR100245957B1 (en) 2000-04-01
WO1996038416A1 (en) 1996-12-05
HUP9700274A2 (en) 1999-06-28
IE960405A1 (en) 1996-12-11
GB9627127D0 (en) 1997-02-19
IL118477A0 (en) 1996-09-12
CZ26997A3 (en) 1997-08-13
JPH09512836A (en) 1997-12-22
SE510812C2 (en) 1999-06-28
BE1009520A5 (en) 1997-04-01
EP0796247A1 (en) 1997-09-24
NL1003243C2 (en) 1996-12-04
KR970704689A (en) 1997-09-06
DK10697A (en) 1997-04-01
ES2137886A1 (en) 1999-12-16
CA2194397A1 (en) 1996-12-05
IT1290839B1 (en) 1998-12-14
AT406675B (en) 2000-07-25

Similar Documents

Publication Publication Date Title
AU4875196A (en) Novel thrombin inhibitors
AU4153197A (en) Phosphinic acid amides as matrix metalloprotease inhibitors
AU3832895A (en) Thrombin inhibitors
AU3435697A (en) N-(4-(Heteroarylmethyl)Phenyl)-Heteroarylamines
AU3102397A (en) Metalloprotease inhibitors
AU7177296A (en) Crystalline hydrochloride of (R)-(-)-2-N-(4- (1,1-dioxido-3-oxo-2,3-dihydro-benzisothiazol-2-yl)-butyl)- aminomethyl-chroman
AU2586299A (en) Method of updating display frames while preserving information associated therewith
AU4201799A (en) Substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors
AU3877095A (en) Modified proteinase inhibitors
IL136231A0 (en) Process for cis-1-{2-[4-(6-methoxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy] ethyl} pyrrolidine
GB2304340B (en) (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy} butyric acid as cellular adhesion inhibitor
AU2938997A (en) Subsituted 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors
AU1502299A (en) Method to identify specific inhibitors of imp dehydrogenase
GB9610093D0 (en) (-)-(3R)-methyl-4-[4-[4-(4-pyridyl) piperazin-1-yl] phenoxy] butyric acid
HU9800511D0 (en) Process for producing 4-{4-[4-(hydroxy-diphenyl)-1-piperidinyl]-1-hydroxy-butyl}-alpha-alpha-dimethyl-phenyl-acetic.acid and phosphorylized derivatives thereof
ZA964509B (en) (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy}butyric acid
AU1448401A (en) Method for dynamic provision of credit information
AU5034699A (en) Matrix metalloproteinase inhibitors containing aminomalonic acid derivatives andpeptide backbone modified derivatives thereof
AU7647998A (en) Substituted 4-(3-alkenyl-benzoyl)-pyrazoles
AU4595100A (en) ((e),3(r))-enantiomer of 4-(3-chloro -4-cyanophenyl) -1-(p- methylsulphonyl -phenylsulphonyl) -2-trifluoromethylbut -trans-3-en-ol
AU6657598A (en) Method of identification of novel substrates
AU3145599A (en) (s)-2-(biphenyl-4-sulphonylamino)-3-(1h-indolyl)-propionic acid derivatives as matrix metal protein inhibitors
KR970000223A (en) Cholesterol biosynthesis inhibitors
IL160749A0 (en) Process and intermediate for cis-1-{2-[4-(6-methoxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl-) phenoxy] ethyl}pyrrolidine
IT1275260B (en) NAIL PARTICULARLY FOR FOOTWEAR

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)
PCNP Patent ceased through non-payment of renewal fee